https://www.pharmaceutical-business-review.com/news/merck-wins-first-fosamax-state-court-case-150211/ 2011-02-14T22:28:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-bio-licenses-ed-drug-vitaros-rights-to-neopharm-in-israel-150211/ 2011-02-14T22:45:00+00:00 https://www.pharmaceutical-business-review.com/news/assurerx-expands-genesightrx-to-help-physicians-individualize-treatment-150211/ 2011-02-14T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/aoxing-pharma-revenues-rise-247-in-q2-fy-11-150211/ 2011-02-14T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pegasystems-unveils-life-sciences-industry-foundation-150211/ 2011-02-14T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/bone-drugs-likely-to-reduce-colon-cancer-risk-in-menopause-women-new-study-150211/ 2011-02-14T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-agrees-to-acquire-glycosan-biosystems-150211/ 2011-02-14T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-plans-partnerships-with-academia-to-develop-new-drugs-150211/ 2011-02-15T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/success-rate-of-developing-new-therapies-is-declining-bio-study-150211/ 2011-02-15T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/dutch-bioscience-firm-pantarhei-looks-to-buy-merck-netherlands-unit-150211/ 2011-02-15T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-partners-with-chembridge-to-strengthen-compound-collection-150211/ 2011-02-15T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/shengtai-pharma-q2-net-sales-increase-150211/ 2011-02-15T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/napo-reports-positive-results-from-diarrhoea-drug-study-150211/ 2011-02-15T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/oligonol-has-anti-inflammatory-effect-new-study-150211/ 2011-02-15T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-als-drug-receives-orphan-drug-status-150211/ 2011-02-15T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/polaris-ludwig-institute-initiate-enrollment-for-adi-peg-20-phase-2-trial/ 2011-02-15T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-presents-integrated-technology-platform-150211/ 2011-02-15T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/jomaa-pharma-mmv-to-jointly-develop-novel-malaria-treatment-150211/ 2011-02-15T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/panmure-gordon-helps-e-therapeutics-to-raise-new-funds-150211/ 2011-02-15T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/affymetrix-launches-ng-class-detergents-for-better-protein-analysis-150211/ 2011-02-15T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/veeva-systems-unveils-content-management-solution-for-life-sciences-160211/ 2011-02-15T17:27:00+00:00 https://www.pharmaceutical-business-review.com/news/genus-begins-tumour-drug-trial-160211/ 2011-02-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lifenexus-launches-multi-purpose-electronic-personal-health-card-160211/ 2011-02-15T20:50:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-acquires-amcor-packaging-manufacturing-facility-in-us-160211/ 2011-02-15T22:12:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-medivation-release-prostate-cancer-drug-positive-data-160211/ 2011-02-15T22:22:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-issues-gmp-certification-to-alliance-medical-products-irvine-facility-160211/ 2011-02-15T22:32:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-awards-aeolus-biotest-contracts-to-develop-drugs-against-acute-radiation-syndrome-160211/ 2011-02-15T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-adds-primacyt-in-vitro-products-services-for-drug-discovery-research-160211/ 2011-02-15T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/acc-aha-hrs-tip-dabigatran-as-an-alternative-treatment-for-atrial-fibrillation-160211/ 2011-02-15T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-agrees-to-buy-genzyme-for-19bn-report-160211/ 2011-02-16T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/therabiogen-makes-theramax-nasal-spray-products-available-in-market-160211/ 2011-02-16T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-india-receives-generic-drug-formulations-purchase-order-from-sri-lanka-160211/ 2011-02-16T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cdrd-ngdi-ubc-partner-to-develop-treatments-for-neglected-global-diseases-160211/ 2011-02-16T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/basi-launches-new-drug-discovery-services-160211/ 2011-02-16T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-sunnybrook-to-jointly-develop-diabetic-foot-ulcer-treatment-160211/ 2011-02-16T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/amneal-enterprises-oculus-in-multi-year-collaboration-for-microcyn-based-drugs-devices-160211/ 2011-02-16T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-mirror-portfolio-receives-licenses-for-two-investigational-medicines-160211/ 2011-02-16T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/imgm-laboratories-deploys-fluidigm-access-array-system-160211/ 2011-02-16T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gets-non-exclusive-access-to-pfenex-expression-technology-160211/ 2011-02-16T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-inks-strategic-partnership-with-covance-quintiles-160211/ 2011-02-16T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/irish-medicines-board-grants-non-prescription-status-to-hra-pharma-emergency-contraceptive-drug-160211/ 2011-02-16T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/preflucel-effective-against-seasonal-influenza-baxter-160211/ 2011-02-16T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nuance-3m-partner-to-deliver-icd-10-ready-clinical-documentation-solutions-170211/ 2011-02-16T18:55:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-aveo-pharma-sign-agreement-to-develop-commercialize-tivozanib-outside-of-asia-170211/ 2011-02-16T22:27:00+00:00 https://www.pharmaceutical-business-review.com/news/pdl-biopharma-medimmune-settle-synagis-patent-dispute-170211/ 2011-02-16T22:45:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-receives-barda-contract-to-develop-broad-spectrum-antiviral-drug-170211/ 2011-02-16T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-unit-janssen-recalls-70000-schizophrenia-drug-injections-170211/ 2011-02-16T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-classifies-product-labelling-corrections-to-synchromed-infusion-pump-refill-as-class-i-recall-170211/ 2011-02-16T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-pharma-fda-sign-spa-agreement-on-sarcoma-drug-phase-3-trial/ 2011-02-16T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-celgene-vizada-for-use-in-the-nhs-in-england-wales-170211/ 2011-02-17T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/zymes-receives-michael-fox-foundation-grant-for-research-on-pd-therapy-170211/ 2011-02-17T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-updates-on-fabry-disease-drug-phase-2-extension-study-170211/ 2011-02-17T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-roche-initiate-lymphoma-drug-mabthera-trial-170211/ 2011-02-17T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/us-marshals-seize-unapproved-ear-infection-drug-auralgan-otic-solution-170211/ 2011-02-17T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/metagenics-proprietary-dietary-supplement-available-in-once-a-day-dosing-170211/ 2011-02-17T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sucanon-middle-east-clinical-trials-in-final-stage-fero-industries-170211/ 2011-02-17T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/us-patent-for-vical-cytomegalovirus-vaccines-170211/ 2011-02-17T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/propel-receives-chicago-community-trust-grant-ibio-institute-170211/ 2011-02-17T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/spanish-ministry-of-health-grants-reimbursement-to-spasticity-drug-sativex-170211/ 2011-02-17T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/diartis-receives-investments-from-index-ventures-amunix-170211/ 2011-02-17T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/mymetics-releases-hiv-vaccine-preclinical-trial-data-170211/ 2011-02-17T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/genetech-cancer-drug-can-prevent-retinopathy-of-prematurity-new-study-170211/ 2011-02-17T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-anti-malaria-drug-not-harmful-for-pregnant-women-study-170211/ 2011-02-17T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pepid-adds-high-quality-pill-pictures-to-clinical-decision-support-data-170211/ 2011-02-17T17:25:00+00:00 https://www.pharmaceutical-business-review.com/news/organizedwisdom-xtify-partner-to-offer-mobile-health-notifications-180211/ 2011-02-17T17:52:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-bristol-myers-abilify-approved-as-adjunct-treatment-in-bipolar-i-disorder-180211/ 2011-02-17T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/biostorage-to-offer-services-to-members-of-amdec-180211/ 2011-02-17T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/medlink-expands-information-exchange-interoperability-platform-180211/ 2011-02-17T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/china-biotics-applies-for-5-new-patents-180211/ 2011-02-17T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-agamatrix-ink-exclusive-sales-distribution-agreement-180211/ 2011-02-18T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/progenics-announces-positive-phase-1-psma-adc-preliminary-data-180211/ 2011-02-18T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-partners-with-nuance-to-apply-watson-technology-to-healthcare-180211/ 2011-02-18T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-fda-start-prevonco-spa-phase-iii-study-discussion-180211/ 2011-02-18T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-naska-north-america-campaign-to-raise-awareness-on-malnutrition-180211/ 2011-02-18T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-launches-promus-taxus-stent-systems-in-india-180211/ 2011-02-18T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/micell-technologies-enrolls-first-patient-in-dessolve-ii-study-180211/ 2011-02-18T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/conatus-begins-hcv-drug-study-180211/ 2011-02-18T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/argus-health-systems-launches-targeted-intervention-strategies-180211/ 2011-02-18T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/arbour-group-expands-west-coast-office-180211/ 2011-02-18T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-pharma-bioniche-to-present-urocidin-phase-iii-trial-results-180211/ 2011-02-18T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-releases-encouraging-cabozantinib-phase-ii-trial-interim-data-180211/ 2011-02-18T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/miragen-polycythemia-vera-drug-receives-orphan-drug-designation-180211/ 2011-02-18T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/inspire-to-undergo-strategic-corporate-restructuring-180211/ 2011-02-18T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/xpedx-sets-up-north-american-package-design-centers-network-250211/ 2011-02-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hayes-clinical-laboratory-to-provide-medlink-isuite-her-210211/ 2011-02-21T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-anti-bacterial-generic-drug-receives-final-fda-approval-210211/ 2011-02-21T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/virxsys-receives-two-us-patents-for-smart-rna-platform-210211/ 2011-02-21T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-announces-three-year-data-of-phase-2-gaucher-disease-oral-compound-210211/ 2011-02-21T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-expands-nationwide-voluntary-recall-of-tablets-210211/ 2011-02-21T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-looks-to-acquire-generic-otc-brands-in-india-210211/ 2011-02-21T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/j-j-recalls-arthritis-injection-in-us-germany-210211/ 2011-02-21T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-csl-behring-genetic-bleeding-disorder-drug-corifact-210211/ 2011-02-21T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-acquires-antula-210211/ 2011-02-21T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/depsyl-offers-new-solution-for-blood-sugar-management-210211/ 2011-02-21T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/hitachi-data-systems-introduces-new-information-management-solution-220211/ 2011-02-21T19:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-introduces-two-new-emr-solutions-220211/ 2011-02-21T19:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pegasystems-introduces-new-crm-solution-for-healthcare-payers-220211/ 2011-02-21T20:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-ivi-partner-to-support-dengue-vaccine-initiative-220211/ 2011-02-21T22:31:00+00:00 https://www.pharmaceutical-business-review.com/news/azelis-agrees-to-acquire-sd-group-220211/ 2011-02-21T22:48:00+00:00 https://www.pharmaceutical-business-review.com/news/novabiotics-antifungal-drug-novexatin-receives-patents-220211/ 2011-02-21T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/siga-receives-new-request-for-proposal-from-barda-220211/ 2011-02-21T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-initiates-hepatitis-c-drug-global-phase-3-clinical-trials-220211/ 2011-02-21T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sheffield-bio-science-to-supply-wockhardt-recombinant-insulin-to-cell-culture-market-220211/ 2011-02-22T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/advancell-reports-cll-drug-acadra-positive-phase-iiia-results-220211/ 2011-02-22T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-acquires-chinese-drug-decision-support-provider-datong-220211/ 2011-02-22T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fate-reports-ft1050-phase-1b-preliminary-data-receives-odd-220211/ 2011-02-22T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-reports-hcv-drug-study-positive-results-220211/ 2011-02-22T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-initiates-angioedema-drug-rhucin-study-220211/ 2011-02-22T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-updates-on-cancer-compound-phase-iiia-clinical-trial-220211/ 2011-02-22T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/medtrust-avantra-partner-to-develop-biomarker-assays-for-cancer-220211/ 2011-02-22T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-adopts-e-workbook-for-shm-xelantibody-platform-220211/ 2011-02-22T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/microsoft-athenahealth-sign-partnership-240211/ 2011-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clariant-sets-up-medical-and-pharmaceutical-segment-250211/ 2011-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quanterix-novartis-forge-simoa-technology-evaluation-deal-230211/ 2011-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nanostring-unveils-ncounter-human-karyotype-panel-230211/ 2011-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sap-rolls-out-new-business-intelligence-offering-for-healthcare-organizations-230211/ 2011-02-22T18:42:00+00:00 https://www.pharmaceutical-business-review.com/news/wi-fi-alliance-partners-with-continua-health-alliance-230211/ 2011-02-22T20:03:00+00:00 https://www.pharmaceutical-business-review.com/news/caraco-signs-merger-agreement-with-sun-pharma-230211/ 2011-02-22T22:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ico-completes-dme-drug-phase-2-clinical-supply-manufacturing-230211/ 2011-02-22T22:47:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-shire-ink-distribution-supply-deal-for-pentasa-230211/ 2011-02-22T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-to-acquire-calistoga-pharma-for-375m-230211/ 2011-02-22T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/viropro-acquires-contract-process-development-provider-alpha-biologics-230211/ 2011-02-22T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-labs-to-buy-clinical-data-230211/ 2011-02-23T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mmds-receives-us-patent-for-medical-marijuana-patch-230211/ 2011-02-23T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/us-government-awards-grant-to-derma-sciences-wound-healing-drug-230211/ 2011-02-23T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/transpharma-reports-diabetes-patch-study-positive-results-230211/ 2011-02-23T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/iota-kinasedetect-saromics-partner-to-accelerate-drug-discovery-230211/ 2011-02-23T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-files-anda-with-fda-for-psoriasis-ointment-generic-version-230211/ 2011-02-23T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-receives-anda-final-approval-for-gabapentin-oral-solution-230211/ 2011-02-23T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/mwv-makes-preservative-free-pump-available-for-sampling-230211/ 2011-02-23T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-ppd-form-drug-development-collaboration-230211/ 2011-02-23T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-pharma-starts-phase-2-portion-of-pancreatic-cancer-trial-230211/ 2011-02-23T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/benlysta-uptake-will-not-reduce-patient-share-for-rituxan-decision-resources-230211/ 2011-02-23T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pci-biotech-concludes-patient-recruitment-in-phase-iii-cancer-study-240211/ 2011-02-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dsmb-clears-dynavax-phase-3-heplisav-trials-240211/ 2011-02-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/new-renal-cell-carcinoma-drug-votrient-available-on-nhs-250211/ 2011-02-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agendia-mammaprint-assay-wins-fda-clearance-240211/ 2011-02-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/carbogen-amcis-to-restructure-swiss-operations-240211/ 2011-02-23T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-astrazeneca-expand-diabetes-drug-onglyza-label-240211/ 2011-02-23T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/dutch-initiative-for-neglected-tropical-diseases-solutions-development-240211/ 2011-02-23T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-nda-for-hypertension-drug-in-us-240211/ 2011-02-24T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-expands-healthcare-it-portfolio-240211/ 2011-02-24T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/axia-introduces-new-skincare-product-with-proprietary-delivery-system-240211/ 2011-02-24T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/colorcon-expands-nutraficient-product-portfolio-240211/ 2011-02-24T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-files-bla-for-rfxiii-compound-240211/ 2011-02-24T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/caliper-covaris-ink-co-marketing-agreement-240211/ 2011-02-24T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-scarguard-labs-to-sell-scarguard-in-canada-240211/ 2011-02-24T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/immunotope-immunovaccine-receive-us-patent-for-cancer-vaccine-antigens-240211/ 2011-02-24T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-central-laboratory-receives-cap-15189-accreditation-240211/ 2011-02-24T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/tarix-pharma-recruits-first-patient-in-txa127-phase-2-trial-240211/ 2011-02-24T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-begins-heart-failure-drug-study-240211/ 2011-02-24T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nitroglycerin-cream-application-increases-bone-density-in-women-new-study-240211/ 2011-02-24T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/anti-cocaine-alcohol-drug-may-help-in-curing-aids-new-research-240211/ 2011-02-24T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-signs-pact-with-esbatech-240211/ 2011-02-24T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-onyx-start-patient-recruitment-in-phase-3-advanced-breast-cancer-trial-240211/ 2011-02-24T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-reveals-phase-3-strive-study-results-240211/ 2011-02-24T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ingenuity-systems-covance-join-hands-to-support-sequencing-research-240211/ 2011-02-24T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/tranzyme-pharma-norgine-starts-dosing-ulimorelin-in-ulises-phase-3-trial-240211/ 2011-02-24T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/sosei-gets-japan-mhlw-approval-for-norlevo-emergency-contraceptive-pill-240211/ 2011-02-24T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/trophos-completes-cardioprotective-compound-phase-1-study-250211/ 2011-02-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lumedx-introduces-new-ehr-integration-framework-250211/ 2011-02-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bruker-to-take-over-michrom-250211/ 2011-02-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-concludes-ceq508-9-month-toxicology-study-250211/ 2011-02-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/savient-pharma-introduces-krystexxa-in-us-250211/ 2011-02-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-pharma-completes-patient-recruitment-in-libigel-phase-iii-efficacy-trial-250211/ 2011-02-24T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-expects-to-receive-fda-crl-on-xifaxan-snda-250211/ 2011-02-25T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-net-revenues-up-in-q4-250211/ 2011-02-25T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-takes-biocon-help-to-re-enter-into-14bn-global-insulin-market-250211/ 2011-02-25T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/enobia-completes-patient-enrollment-in-bone-disorder-drug-study-250211/ 2011-02-25T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/jhp-pharma-in-manufacturing-pact-with-biotech-firm-250211/ 2011-02-25T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/isofol-medical-gets-swedish-medical-products-agency-approval-for-modufolin-use-250211/ 2011-02-25T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/persistent-systems-to-develop-packaging-solutions-for-aspen-250211/ 2011-02-25T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/medtrust-avantra-to-develop-biomarker-assays-for-cancer-220211/ 2011-02-25T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicare-q4-net-sales-up-250211/ 2011-02-25T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/iq-therapeutics-starts-phase-i-inhalation-anthrax-clinical-trial-250211/ 2011-02-25T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/mts-medication-technologies-appoints-president-250211/ 2011-02-25T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-resolves-abraxane-patent-dispute-with-celgene-250211/ 2011-02-25T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-biomerieux-in-pact-for-personalized-medicine-250211/ 2011-02-25T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cowen-healthcare-royalty-pays-milestone-to-aeterna-zentaris-280211/ 2011-02-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-wins-fda-full-approval-for-itp-treatment-promacta-280211/ 2011-02-27T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-to-acquire-two-merck-units-280211/ 2011-02-28T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-gaucher-diseases-drug-receives-fda-crl-280211/ 2011-02-28T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-partners-with-quintiles-to-foray-into-biopharma-market-280211/ 2011-02-28T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-to-begin-lung-cancer-drug-trial-280211/ 2011-02-28T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-hypertension-drug-edarbi-gets-fda-approval-280211/ 2011-02-28T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/golden-meditech-to-take-over-chinese-herbal-medicine-business-remaining-stake-280211/ 2011-02-28T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-materialscience-to-introduce-new-polyurethane-dispersion-hair-polymer-280211/ 2011-02-28T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/selcia-concludes-drug-discovery-pact-with-exonhit-280211/ 2011-02-28T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-agrees-to-acquire-martek-280211/ 2011-02-28T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-acquires-bmp-sunstone-280211/ 2011-02-28T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-postpones-nerbloc-launch-280211/ 2011-02-28T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/kuros-initiates-kur-023-pilot-study-280211/ 2011-02-28T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/dundee-researchers-discover-gene-responsible-for-self-healing-of-skin-cancer-280211/ 2011-02-28T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-refuses-santarus-pharming-rhucin-bla-280211/ 2011-02-28T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-in-research-pact-with-harvard-university-280211/ 2011-02-28T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-submits-complete-response-to-fda-for-firazyr-nda-280211/ 2011-02-28T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-inaugurates-asia-distribution-center-in-singapore-280211/ 2011-02-28T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-pharma-receives-new-european-patent-280211/ 2011-02-28T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-obtains-fda-priority-review-for-istodax-280211/ 2011-02-28T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-acquires-assets-from-bd-010311/ 2011-02-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/renishaw-introduces-ruo-multiplex-assay-system-010311/ 2011-02-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/veeva-crm-to-support-leo-pharma-european-business-010311/ 2011-02-28T20:47:00+00:00 https://www.pharmaceutical-business-review.com/news/instacare-submits-patent-application-for-mdhand-mdwork-technologies-010311/ 2011-02-28T23:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hp-introduces-drug-research-application-to-support-pharma-firms-010311/ 2011-02-28T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-gabapentin-capsules-010311/ 2011-02-28T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/on-assignment-acquires-valesta-010311/ 2011-02-28T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-derma-sciences-medihoney-wound-gel-010311/ 2011-02-28T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mindray-agrees-to-acquire-shenke-medical-controlling-stake-010311/ 2011-03-01T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-to-acquire-plexxikon-for-935m-010311/ 2011-03-01T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-posts-fourth-quarter-loss-on-schering-write-down-010311/ 2011-03-01T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-announces-positive-phase-1-data-for-hiv-gene-therapy-010311/ 2011-03-01T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-gout-drug-arcalyst-meets-primary-secondary-end-points-010311/ 2011-03-01T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/unstable-chromosomes-cause-resistance-to-cancer-drugs-cancer-research-uk-010311/ 2011-03-01T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/health-robotics-terminates-mckesson-pact-010311/ 2011-03-01T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/affiris-extends-vaccine-development-collaboration-with-gsk-010311/ 2011-03-01T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-products-pays-48m-milestone-to-depomed-010311/ 2011-03-01T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-forest-labs-daliresp-010311/ 2011-03-01T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-vaxinnate-receive-hhs-contract-010311/ 2011-03-01T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-licenses-vlp-vaccine-technology-to-lgls-010311/ 2011-03-01T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-once-daily-guanfacine-tablet-gets-fda-approval-for-adhd-treatment-010311/ 2011-03-01T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-introduces-xerese-in-us-010311/ 2011-03-01T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-selects-ranbaxy-to-market-four-products-in-singapore-010311/ 2011-03-01T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/irx-therapeutics-signs-research-pact-with-pharma-firm-020311/ 2011-03-01T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/supergen-revenues-up-in-q4-010311/ 2011-03-01T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-celsion-thermodox-020311/ 2011-03-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/albemarle-health-installs-imdsoft-metavision-solution-020311/ 2011-03-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clinipace-acquires-regulus-020311/ 2011-03-01T21:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-v-go-disposable-insulin-delivery-device-valeritas-020311/ 2011-03-01T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-king-pharma-020311/ 2011-03-02T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/intercell-q4-revenues-fall-020311/ 2011-03-02T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/axolotl-ehr-version-7-elysium-emr-lite-gets-onc-atcb-certification-020311/ 2011-03-02T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-rectal-gel-can-prevent-hiv-infection-new-study-020311/ 2011-03-02T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/tobira-announces-pharmacokinetic-bioavailability-safety-results-from-cenicriviroc-studies-020311/ 2011-03-02T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vivelle-ventures-noven-pharma-novartis-sue-mylan-020311/ 2011-03-02T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-millennium-begin-lymphoma-drug-trial-020311/ 2011-03-02T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-begins-prostate-cancer-drug-prostvac-study-020311/ 2011-03-02T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/clondalkin-acquires-catalent-printed-components-business-020311/ 2011-03-02T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ert-net-revenues-up-in-q4-020311/ 2011-03-02T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-for-helix-biopharma-020311/ 2011-03-02T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/nektar-q4-revenues-up-020311/ 2011-03-02T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-reveals-phase-iii-clinical-study-of-ms-spasticity-020311/ 2011-03-02T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-reinspects-perrigo-allegan-facility-020311/ 2011-03-02T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-baraclude-gets-european-commission-approval-020311/ 2011-03-02T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/covidien-to-introduce-new-global-packaging-020311/ 2011-03-02T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-pfizer-ink-marketing-distribution-pact-030311/ 2011-03-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-annual-revenue-rises-030311/ 2011-03-02T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-for-emd-serono-cladribine-tablets-nda-030311/ 2011-03-02T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/osiris-concludes-patient-recruitment-in-prochymal-phase-2-trial-030311/ 2011-03-03T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/national-pharmaceuticals-partners-globe-laboratories-for-drug-development-030311/ 2011-03-03T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ibuprofen-use-may-reduce-parkinsons-risk-new-harvard-study-030311/ 2011-03-03T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-reports-phase-2-data-for-metastatic-melanoma-treatment-formulation-030311/ 2011-03-03T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gtx-ipsen-to-suspend-toremifene-pact-030311/ 2011-03-03T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-initiates-action-to-remove-unapproved-drugs-030311/ 2011-03-03T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-initiates-endopeptidase-drug-candidate-trials-030311/ 2011-03-03T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/us-army-grants-fund-for-oxycyte-study-oxygen-biotherapeutics-030311/ 2011-03-03T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-handa-pharma-generic-dexilant-anda-030311/ 2011-03-03T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/iti-takeda-pharma-ink-agreement-to-develop-compounds-for-schizophrenia/ 2011-03-03T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-licenses-gs-9219-to-vetdc-030311/ 2011-03-03T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-bruker-enter-co-development-pact-for-dietary-supplement-testing-030311/ 2011-03-03T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/remitdata-signs-remitpartner-program-agreement-with-transunion-030311/ 2011-03-03T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-research-names-new-president-030311/ 2011-03-03T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/act-biotech-submits-spa-for-telatinib-phase-3-trial-with-fda-010311/ 2011-03-03T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/orasure-roche-get-fda-clearance-for-four-oral-fluid-drugs-of-abuse-assays-040311/ 2011-03-03T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/steria-neology-ink-pact-to-develop-rfid-solutions-040311/ 2011-03-03T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisai-banzel-oral-suspension-40mgml-040311/ 2011-03-04T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/transcend-to-take-over-dts-america-040311/ 2011-03-04T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-calls-off-gsk-pact-040311/ 2011-03-04T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-begins-chondrosarcoma-drug-trial-040311/ 2011-03-04T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/novabay-commences-urinary-tract-infection-drug-trial-040311/ 2011-03-04T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-signs-research-agreement-with-merck-040311/ 2011-03-04T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-pulmonary-fibrosis-drug-receives-eu-approval-040311/ 2011-03-04T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/allos-sings-agreement-with-fda-for-folotyn-phase-3-trial-design-040311/ 2011-03-04T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/amyris-in-contract-manufacturing-pact-with-antibioticos-040311/ 2011-03-04T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonomix-forms-new-subsidiary-040311/ 2011-03-04T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ricerca-partners-with-fulcrum-pharma-aptiv-solutions-040311/ 2011-03-04T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-establishes-new-clinical-trial-supply-depot-in-singapore-070311/ 2011-03-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/china-shengda-packaging-to-set-up-paper-manufacturing-plant-110311/ 2011-03-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/terumo-to-buy-caridianbct-070311/ 2011-03-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-gets-fda-acceptence-for-clobazam-nda-review-070311/ 2011-03-07T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-rheumatoid-arthritis-drug-meets-primary-endpoint-070311/ 2011-03-07T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/topiramate-linked-to-birth-defects-fda/ 2011-03-07T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/aratana-raqualia-sign-agreement-to-develop-two-animal-health-drugs-070311/ 2011-03-07T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-pharma-obtains-fda-approval-for-oral-contraceptive-drug-070411/ 2011-03-07T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/instem-takes-over-biowisdom-070311/ 2011-03-07T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-suspends-prevnar-acthib-following-deaths-070311/ 2011-03-07T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/phase-2-atrasentan-study-for-diabetic-kidney-disease-delivers-positive-results-abbott-070311/ 2011-03-07T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-acquires-biovex-070311/ 2011-03-07T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-galderma-pharma-sign-rd-pact-070311/ 2011-03-07T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sareum-reveals-positive-chk1-programme-model-study-results-070311/ 2011-03-07T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/twinlab-rolls-out-power-fuel-pre-workout-supplement-070311/ 2011-03-07T09:08:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-pharma-reveals-positive-pre-clinical-results-on-nasal-drug-delivery-technology-080311/ 2011-03-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tolmar-selects-pilgrim-software-to-streamline-processes-080311/ 2011-03-07T20:40:00+00:00 https://www.pharmaceutical-business-review.com/news/alliqua-completes-transdermal-pain-patch-preliminary-in-vitro-permeation-study-080311/ 2011-03-08T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-bipolar-depression-drug-fails-in-study/ 2011-03-08T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-iowh-to-develop-antibiotics-for-bloody-diarrhoea-080311/ 2011-03-08T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-enters-into-partnership-with-wuxi-080311/ 2011-03-08T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/excelsior-medical-swabflush-gets-fda-clearance-080311/ 2011-03-08T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/insys-files-nda-for-fentanyl-sl-spray-with-fda-080311/ 2011-03-08T04:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-discontinues-production-of-pulmicort-pmdi-080311/ 2011-03-08T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-names-new-president-080311/ 2011-03-08T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/simcere-pharma-q4-revenues-up-76-080311/ 2011-03-08T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/kamada-gets-israel-patent-for-ultrapure-transferrin-100311/ 2011-03-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/borealis-inaugurates-new-catalyst-plant-in-austria-090311/ 2011-03-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/huya-bioscience-wuhan-biolake-ink-collaborative-alliance-090311/ 2011-03-09T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-bristol-myers-astrazeneca-type-2-diabetes-investigational-compound-nda-090311/ 2011-03-09T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/plexxikon-begins-hodgkin-lymphoma-drug-trial-090311/ 2011-03-09T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-yakult-honsha-in-pact-for-perifosine-090311/ 2011-03-09T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-labs-allergy-asthma-research-institute-sign-up-with-safe-biopharma-association-090311/ 2011-03-09T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-copd-drug-gets-fda-advisory-committee-recommendation-090311/ 2011-03-09T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/geospiza-nugen-in-pact-to-accelerate-discoveries-for-research-studies-090311/ 2011-03-09T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ipca-manufacturing-site-receives-mhra-approval-090311/ 2011-03-09T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cross-country-healthcare-revenues-falls-in-q4-090311/ 2011-03-09T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/heraeus-to-roll-out-venus-bulk-fill-syringes-090311/ 2011-03-09T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-obtains-fda-approval-for-somatuline-depot-injection-extended-dosing-interval-090311/ 2011-03-09T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/qps-acquires-majority-stake-in-qualitix-090311/ 2011-03-09T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-for-recall-vaxtm-technology-platform-intellect-090311/ 2011-03-09T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/global-health-concludes-x-excite-trial-in-men-090311/ 2011-03-09T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/genus-oncology-go-203-2c-gets-fda-orphan-drug-status-090311/ 2011-03-09T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-orphan-drug-status-to-tasimelteon-vanda-pharma-090311/ 2011-03-09T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-explores-opportunities-to-invest-in-brazil-110311/ 2011-03-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lanxess-starts-work-at-new-compounding-facility-in-us-110311/ 2011-03-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-unveils-new-technology-portal-for-patient-retention-in-clinical-trials-100311/ 2011-03-09T19:56:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-extends-agreement-with-bristol-myers-squibb-100311/ 2011-03-09T23:06:00+00:00 https://www.pharmaceutical-business-review.com/news/bts-deploys-estudy-solution-to-manage-glp-non-glp-preclinical-studies-100311/ 2011-03-09T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ibc-pharma-to-get-two-additional-patents-for-dock-and-lock-technology-100311/ 2011-03-10T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-hgs-gsk-systemic-lupus-erythematosus-drug-benlysta-100311/ 2011-03-10T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-q4-net-sales-down-100311/ 2011-03-10T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-saflutan-nda-merck-100311/ 2011-03-10T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-injectable-product-with-nanocrystal-technology-gets-european-approval/ 2011-03-10T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/pepscan-crucell-sign-research-licensing-agreement-100311/ 2011-03-10T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/top-secret-nutrition-unveils-diet-accelerator-n-pack-with-innoslim-100311/ 2011-03-10T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-commences-phase-i-san-300-trial-100311/ 2011-03-10T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/taris-starts-phase-1b-interstitial-cystitis-trial-100311/ 2011-03-10T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-extended-release-carbinoxamine-oral-suspension-receives-fda-acceptance-100311/ 2011-03-10T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-pharma-completes-enrollment-in-graspa-phase-ii-clinical-trial-100311/ 2011-03-10T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-forms-research-pact-with-harvard-university-100311/ 2011-03-10T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/action-medical-research-awards-oxford-grant-to-develop-meningitis-vaccine-for-children-100311/ 2011-03-10T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/grace-inaugurates-technical-service-centre-in-india-100311/ 2011-03-10T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/creabilis-releases-phase-iia-psoriasis-vulgaris-study-results-100311/ 2011-03-10T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/brenntag-establishes-chemical-distribution-facility-in-indonesia-100311/ 2011-03-10T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-takes-over-antisoma-anticancer-compound-100311/ 2011-03-10T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-pharma-concludes-phase-2-epilepsy-trial-100311/ 2011-03-10T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/act-receives-comp-positive-opinion-for-hesc-derived-rpe-cells-100311/ 2011-03-10T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-final-approval-for-mylan-zidovudine-tablets-110311/ 2011-03-10T22:03:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-for-marqibo-talon-therapeutics-110311/ 2011-03-11T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-signs-pact-with-epizyme-110311/ 2011-03-11T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-concludes-pharmaswiss-acquisition-110311/ 2011-03-11T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-mhlw-approves-chugai-pharma-herceptin-for-additional-indication-110311/ 2011-03-11T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-presents-vx-765-phase-2-study-results-110311/ 2011-03-11T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-releases-phase-i-clinical-trial-results-of-ev71-vaccine-110311/ 2011-03-11T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/sunesis-secures-european-patent-covering-vosaroxin-110311/ 2011-03-11T02:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/atagi-recommends-influenza-vaccine-use-in-children-110311/ 2011-03-11T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/avaxia-biologics-gets-phase-i-sbir-grant-110311/ 2011-03-11T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharmaceuticals-to-expand-kinston-manufacturing-plant-110311/ 2011-03-11T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-lung-cancer-drug-fails-to-meet-primary-endpoint-110311/ 2011-03-11T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-diabetic-macular-edema-drug-meets-primary-endpoint-110311/ 2011-03-11T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/jasco-pharma-nccu-signs-research-pact-110311/ 2011-03-11T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/spencer-pharma-enters-into-agreement-with-polyvalor-110311/ 2011-03-11T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-revenues-up-in-q4-110311/ 2011-03-11T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biotron-concludes-hepatitis-c-drug-phase-2-trial-first-stage-110311/ 2011-03-11T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-fy10-revenues-down-110311/ 2011-03-11T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-moh-approves-nectar-cefuroxime-axetil-110311/ 2011-03-11T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-q4-revenue-falls-110311/ 2011-03-11T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-recruits-first-patient-in-fap-trial-140311/ 2011-03-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elanco-plans-to-take-over-janssen-animal-health-business-140311/ 2011-03-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medecision-hli-sign-pact-140311/ 2011-03-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-deficiency-letter-to-scolr-pharma-140311/ 2011-03-14T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/national-research-council-awards-grant-to-national-pharma-140311/ 2011-03-14T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-initiates-phase-ib-cancer-trial-140311/ 2011-03-14T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-pharma-q3-revenue-falls-140311/ 2011-03-14T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/tolerx-gsk-fail-to-meet-primary-endpoint-in-defend-1-study-140311/ 2011-03-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-doses-first-patient-in-phase-ii-bi-204-trial-140311/ 2011-03-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/inovio-chrontech-begin-hcv-vaccine-trial-with-electroporation-delivery-technology-140311/ 2011-03-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/chroma-licenses-cti-to-co-develop-market-tosedostat-140311/ 2011-03-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/protaffin-gets-european-patent-for-celljammer-discovery-technology-140311/ 2011-03-14T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-adhd-drug-meets-primary-endpoints-140311/ 2011-03-14T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/once-monthly-injectable-exenatide-improves-glucose-control-study-140311/ 2011-03-14T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/biospecifics-technologies-q4-revenues-up-140311/ 2011-03-14T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/top-institute-pharma-develops-new-nanotechnology-140311/ 2011-03-14T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/labopharm-names-new-president-ceo-140311/ 2011-03-14T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/berkshire-hathaway-to-buy-specialty-chemical-firm-lubrizol-140311/ 2011-03-14T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/imdx-licenses-ivd-products-to-biosearch-150311/ 2011-03-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-approves-new-patent-for-nutra-pharma-cobratoxin-150311/ 2011-03-15T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-gadavist-injection-gets-fda-aaproval-150311/ 2011-03-15T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-q4-revenues-up-26-150311/ 2011-03-15T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-initiates-leukaemia-drug-study-150311/ 2011-03-15T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-completes-patient-enrolment-in-psoriasis-drug-trial-150311/ 2011-03-15T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/lifevantage-names-new-president-ceo-150311/ 2011-03-15T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-licenses-non-dna-vaccine-technology-to-oncosec-medical-150311/ 2011-03-15T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-q4-revenue-rises-150311/ 2011-03-15T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/almirall-launches-sativex-in-spain-150311/ 2011-03-15T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bruker-unveils-high-performance-gc-care-columns-150311/ 2011-03-15T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gea-lyophil-vapovac-freeze-dryer-technology-150311/ 2011-03-15T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/surya-healthcare-acquires-medimart-pharmacy-150311/ 2011-03-15T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/oral-anti-cancer-agent-teysuno-gets-european-marketing-authorization-150311/ 2011-03-15T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fette-establishes-competence-centre-in-goa-150311/ 2011-03-15T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-comfort-ii-study-meets-primary-endpoint-150311/ 2011-03-15T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-to-acquire-irish-manufacturing-plant-from-pfizer-150311/ 2011-03-15T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cerenis-commences-phase-2-chi-square-acute-coronary-syndrome-trial-150311/ 2011-03-15T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-starts-kevetrin-production-for-clinical-trials-150311/ 2011-03-15T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-licenses-acuform-drug-delivery-technology-to-boehringer-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-partners-with-oxford-nanopore-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-pharma-regains-all-ampakine-assets-rights-from-biovail-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-roche-file-case-against-natco-pharma-over-tamiflu-us-patent-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-intralytix-phage-based-e-coli-technology-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/enzo-life-sciences-launches-smn-protein-assay-system-160311/ 2011-03-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/plexxikon-chooses-clinipace-to-manage-four-clinical-trials-160311/ 2011-03-15T19:05:00+00:00 https://www.pharmaceutical-business-review.com/news/nerviano-medical-sciences-novartis-sign-license-agreement-160311/ 2011-03-16T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-recruits-first-patient-in-opioid-induced-constipation-trial-160311/ 2011-03-16T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-invests-in-medical-plastic-systems-business-unit-160311/ 2011-03-16T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/adocia-reveals-positive-trial-results-on-diabetes-drug-160311/ 2011-03-16T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-receives-bfarm-approval-to-conduct-phase-i-trial-160311/ 2011-03-16T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/photocure-sagentia-to-test-drug-device-for-hpv-cervical-pre-cancer-160311/ 2011-03-16T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/materia-intends-to-establish-catalyst-manufacturing-plant-in-singapore-160311/ 2011-03-16T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-initiates-osteoporosis-drug-study-160311/ 2011-03-16T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-myelofibrosis-meets-primary-endpoint-in-study-160311/ 2011-03-16T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-millennium-collaborate-to-expand-adc-160311/ 2011-03-16T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mbl-licenses-rip-chip-technology-to-envoy-160311/ 2011-03-16T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-concludes-patient-recruitment-in-talactoferrin-phase-iii-fortis-m-trial-160311/ 2011-03-16T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-type2-diabetes-drug-receives-sfda-approval-160311/ 2011-03-16T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-invests-in-zed-walleting-170311/ 2011-03-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-osi-genentech-pfizer-settle-lung-cancer-drug-patent-case-170311/ 2011-03-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-ema-unveil-pilot-program-for-qbd-applications-parallel-assessment-170311/ 2011-03-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/srs-obtains-government-certification-for-ehr-170311/ 2011-03-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-files-case-against-alnylam-pharma-for-trade-secrets-misuse-170311/ 2011-03-16T22:15:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-takeda-halt-obesity-drug-phase-2-study-170311/ 2011-03-16T22:28:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-selects-pharmapros-dataflow-manager-170311/ 2011-03-16T22:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/hgs-to-develop-commercialize-fiveprime-therapeutics-novel-anti-cancer-drug-170311/ 2011-03-16T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/us-patent-for-achillion-hcv-drug-related-compounds-170311/ 2011-03-16T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-notice-on-rgn-352-clinical-hold-for-gmp-compliance-issues-170311/ 2011-03-17T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-plans-to-close-horsham-rd-site-in-uk-170311/ 2011-03-17T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-boehringer-ingelheim-sign-manufacturing-pact-170311/ 2011-03-17T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/akrimax-pharma-introduces-nitromist-400mcgspray-170311/ 2011-03-17T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fero-industries-introduces-otc-type-2-diabetes-drug-in-mexico-170311/ 2011-03-17T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/spanish-regulatory-medicine-agency-grants-to-initiate-cardiotrophin-i-trial-170311/ 2011-03-17T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/psioxus-initiates-phase-ii-trial-for-wasting-disease-therapeutic-170311/ 2011-03-17T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaron-signs-agreement-with-isis-pharma-170311/ 2011-03-17T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bluebird-bio-afm-enter-into-sickle-cell-anemia-drug-research-agreement-170311/ 2011-03-17T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/zeavision-advances-eyepromise-restore-170311/ 2011-03-17T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-receives-new-us-patent-for-prostate-cancer-drug-170311/ 2011-03-17T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/xl-protein-gets-european-patent-for-pasylation-technology-170311/ 2011-03-17T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-widens-its-pact-with-medidata-solutions-180311/ 2011-03-17T18:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-q4-net-loss-widens-180311/ 2011-03-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mwv-healthcare-packaging-plant-receives-fsc-certification-210311/ 2011-03-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/taimed-biologics-signs-licensing-pact-with-ambrilia-biopharma-180311/ 2011-03-18T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-q1-net-sales-up-321-180311/ 2011-03-18T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharma-voluntarily-recalls-product-lot-no-1037180-in-canada-180311/ 2011-03-18T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharma-tpn-settle-litigation-over-product-agreement-180311/ 2011-03-18T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-pharma-mmv-sign-agreement-for-malaria-drug-development-180311/ 2011-03-18T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmadiagnostics-unveils-new-coupling-methods-for-soprano-label-free-platform-180311/ 2011-03-18T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrilia-biopharma-zbx-ink-licensing-pact/ 2011-03-18T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-against-ucb-fibromyalgia-drug-180311/ 2011-03-18T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrogen-astellas-commence-anemia-drug-trial-in-ckd-180311/ 2011-03-18T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/nupathe-q4-net-loss-widens-180311/ 2011-03-18T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-for-amyvid-nda-eli-lilly-avid-180311/ 2011-03-18T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-contraceptive-pill-gets-chmp-positive-opinion-180311/ 2011-03-18T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/croma-pharma-obtains-chmp-positive-opinion-for-yellox-180311/ 2011-03-18T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-exco-intouch-partner-to-deliver-patient-compliance-epro-services-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nektar-doses-first-patient-in-pain-drug-trial-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/polaris-recruits-first-patient-in-malignant-mesothelioma-drug-trial-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ventrus-submits-revised-protocol-for-iferanserin-trial-with-fda-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bd-acquires-accuri-cytometers-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/raindance-launches-asdseq-xseq-research-screening-panels-210311/ 2011-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teledyne-dalsa-to-unveil-boa-idr-for-parts-tracking-verification-210311/ 2011-03-20T20:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-to-unveil-cellulosic-food-solutions-210311/ 2011-03-21T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-grants-marketing-authorization-for-sanofi-aventis-jevtana-210311/ 2011-03-21T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-phase-ii-vismodegib-study-meets-primary-endpoint-210311/ 2011-03-21T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/bafna-pharma-to-acquire-raricap-from-jj-210311/ 2011-03-21T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-develops-new-pk-model-for-subcutaneous-immunoglobulin-g-210311/ 2011-03-21T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-gets-chmp-negative-opinion-for-vectibix-marketing-authorization-application-210311/ 2011-03-21T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-commences-pixantrone-trial-210311/ 2011-03-21T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-zydus-cadila-widen-research-pact-210311/ 2011-03-21T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-pharma-invida-expand-dermatology-collaboration-to-include-india-210311/ 2011-03-21T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/irish-pharma-firm-university-of-ulster-form-research-partnership-210311/ 2011-03-21T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gea-pharma-systems-christian-berner-sign-agreement-210311/ 2011-03-21T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/mucosis-initiates-influenza-vaccine-flugem-clinical-study-210311/ 2011-03-21T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-pharma-gets-us-dod-sbir-award-210311/ 2011-03-21T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sage-bionetworks-collaborates-with-astrazeneca-210311/ 2011-03-21T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-gilenya-210311/ 2011-03-21T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmstar-names-new-ceo-210311/ 2011-03-21T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-takes-over-nystatin-oral-suspension-anda-210311/ 2011-03-21T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/curemark-concludes-patient-recruitment-in-autism-drug-trial-210311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-pharma-meets-fda-over-metastatic-melanoma-trial-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-introduces-reminyl-in-japan-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tesaro-signs-licensing-deal-with-amgen-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharma-receives-fda-acceptance-for-zevalin-review-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-takes-over-brazilian-packaging-company-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-melanoma-drug-meets-primary-endpoint-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-gerd-drug-fails-to-meet-primary-endpoint-220311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-arisaph-ind-application-for-dyslipidemia-drug-230311/ 2011-03-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/multisorb-deploys-dyadem-stature-for-quality-risk-management-220311/ 2011-03-21T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/document-security-systems-receives-new-patents-for-brand-protection-technology-220311/ 2011-03-21T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-herpes-drug-famciclovir-220311/ 2011-03-22T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/unmet-needs-still-exist-among-allergic-rhinitis-patients-nasl-2010-220311/ 2011-03-22T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-to-acquire-gemin-x-pharma-220311/ 2011-03-22T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-sanofi-aventis-suspend-animal-health-business-pact-220311/ 2011-03-22T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-acquires-majority-stake-in-zhejiang-tianyuan-220311/ 2011-03-22T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mwi-buys-nelson-laboratories-220311/ 2011-03-22T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ppg-industries-to-take-over-equa-chlor-assets-220311/ 2011-03-22T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/five-years-of-tamoxifen-reduces-cancer-study-220311/ 2011-03-22T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/quark-reports-results-from-diabetic-macular-edema-drug-study-210311/ 2011-03-22T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-files-lawsuit-against-fda-220311/ 2011-03-22T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/isogenica-collaborates-with-jjprd-220311/ 2011-03-22T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-anticipates-thyrogen-drug-shortage-220311/ 2011-03-22T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-pharma-recruits-30-of-patients-in-phase-iib-mdd-trial-230311/ 2011-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-ranitidine-syrup-gets-fda-approval-230311/ 2011-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grunenthal-takes-over-nectid-pain-patent-portfolio-230311/ 2011-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alliance-pharmaceuticals-to-acquire-reckitt-benckiser-brands-230311/ 2011-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/asuragen-unveils-amplidex-fmr1-pcr-kit-in-europe-230311/ 2011-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-licenses-adc-technology-to-abbott-230311/ 2011-03-22T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-files-generic-azilsartan-nda-with-mhlw-230311/ 2011-03-22T22:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-pharma-introduces-acetadote-injection-230311/ 2011-03-23T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-eisai-advanced-breast-cancer-drug-230311/ 2011-03-23T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cellerant-initiates-leukaemia-drug-trial-230311/ 2011-03-23T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-tentative-approval-for-aurobindo-pharma-famciclovir-tablets-230311/ 2011-03-23T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-reports-positive-results-from-eye-inflammation-drug-study-230311/ 2011-03-23T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/globe-labs-licenses-glb333-to-national-pharma/ 2011-03-23T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-sativex-gets-recommendation-for-approval-in-six-european-countries-230311/ 2011-03-23T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-novartis-copd-drug-nda-review-period-230311/ 2011-03-23T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/idt-biologika-to-invest-eur85m-in-germany-230311/ 2011-03-23T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-receives-us-patent-for-talactoferrin-230311/ 2011-03-23T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-inspects-lannett-philadelphia-manufacturing-facility-230311/ 2011-03-23T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-elvitegravir-phase-iii-trial-meets-primary-objective-230311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmerica-introduces-advanced-ez-mar-230311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alpharx-gets-notice-of-allowance-for-pain-drug-240311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-pharma-toresmide-tablets-win-fda-approval-240311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-lidocaine-hcl-jelly-2-receives-fda-final-approval-240311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-dabigatran-etexilate-cost-effective-for-preveting-stroke-in-atrial-fibrillation-study-240311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-offers-omega-coronary-stent-system-in-uk-240311/ 2011-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/icad-q4-revenue-falls-21-240311/ 2011-03-23T22:47:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-selects-xirrus-for-wireless-connectivity-240311/ 2011-03-23T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-releases-prolia-study-results-240311/ 2011-03-24T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/wellcome-trust-grants-canbex-translation-award-to-develop-ms-drug-240311/ 2011-03-24T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-nephrx-240311/ 2011-03-24T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-diabetes-drug-fails-to-meet-primary-endpoint-240311/ 2011-03-24T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-partners-with-cilag-for-migraine-drug-240311/ 2011-03-24T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/kalexsyn-biorelix-extend-anti-bacterial-drug-discovery-collaboration/ 2011-03-24T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approval-for-actavis-valacyclovir-hydrochloride-tablets-240311/ 2011-03-24T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-generics-oral-contraceptive-gets-fda-nod-240311/ 2011-03-24T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/trius-reports-rise-in-q4-revenues-240311/ 2011-03-24T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bioindustry-association-applauds-uk-government-initiatives-240311/ 2011-03-24T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-uluru-altrazeal-240311/ 2011-03-24T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-withdraw-avodart-regulatory-applications-240311/ 2011-03-24T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-in-research-pact-with-columbia-university-medical-center-250311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-sells-solabegron-assets-to-altherx-250311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/titan-pharma-q4-revenues-up-250311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mersana-starts-phase-1b-extension-gastric-cancer-drug-trial-250311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-forms-new-subsidiary-in-china-250311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-signs-three-year-research-pact-290311/ 2011-03-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/a-cube-protevobio-to-jointly-construct-biobetter-monoclonal-antibodies-250311/ 2011-03-24T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-acquires-amgen-fremont-facility-250311/ 2011-03-24T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-procter-gamble-forge-consumer-health-care-partnership-250311/ 2011-03-24T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/extedo-to-boost-sales-support-services-in-southeast-europe-250311/ 2011-03-25T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-rules-in-favor-of-cephalon-in-watson-case-250311/ 2011-03-25T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/german-ministry-of-education-funds-aeterna-zentaris-to-develop-anti-cancer-compounds/ 2011-03-25T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/althea-expands-packaging-services-under-sherpa-pact-250311/ 2011-03-25T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/vectura-reveals-phase-ii-cystic-fibrosis-drug-trial-results-250311/ 2011-03-25T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biotage-launches-new-workstation-for-microwave-assisted-peptide-synthesis-250311/ 2011-03-25T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/targacepts-adhd-drug-fails-to-meet-primary-endpoint-250311/ 2011-03-25T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-merck-shingles-vaccine-approval-250311/ 2011-03-25T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-medical-starts-patient-recruitment-phase-iii-cruise-1-study-250311/ 2011-03-25T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/graceway-pharma-genital-warts-treatment-gets-fda-approval-250311/ 2011-03-25T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/tarsa-releases-positive-results-from-osteoporosis-drug-phase-iii-trial-250311/ 2011-03-25T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-expands-to-south-east-europe-280511/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-metastatic-melanoma-drug-receives-fda-approval-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-levocetirizine-tablets-5mg-in-us-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-q4-net-loss-narrows-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/versartis-begins-growth-hormone-deficiency-drug-trial-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-medical-inks-supply-pact-with-davita-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-doses-first-patient-in-g-202-trial-280311/ 2011-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-diabetic-macular-edema-drug-lucentis-meets-primary-endpoint-280311/ 2011-03-28T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ortho-mcneil-janssen-pharma-commences-schizophrenia-drug-trial-280311/ 2011-03-28T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-licenses-flt-assays-to-biofocus-280311/ 2011-03-28T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-files-teduglutide-maa-with-ema-280311/ 2011-03-28T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/nmss-funds-adeona-pharma-trimesta-clinical-trial-280311/ 2011-03-28T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/tpp-university-of-aberdeen-partner-to-develop-drugs-280311/ 2011-03-28T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/andrx-labs-watson-file-generic-oxycontin-anda-280311/ 2011-03-28T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-introduces-new-crm-solution-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/terrassa-keyplants-form-strategic-alliance-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-unveils-new-clinical-trials-mobile-application-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/emerald-chemdiv-ink-drug-discovery-development-pact-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oncodesign-acquires-human-colorectal-cancer-models-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/phlexglobal-completes-management-buyout-290311/ 2011-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-to-re-introduce-mykidz-iron-supplements-290311/ 2011-03-28T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/chiltern-establishes-new-office-in-netherlands-290311/ 2011-03-29T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mb-innovations-to-launch-weight-loss-supplement-290311/ 2011-03-29T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/natco-cancer-drug-receives-fda-orphan-drug-designation-290311/ 2011-03-29T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bionovo-begins-enrollment-in-menopausal-hot-flushes-drug-trial-290311/ 2011-03-29T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-pharma-gets-10m-under-takeda-alliance-290311/ 2011-03-29T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/jhp-pharma-in-muti-year-contract-manufacturing-pact-with-biotech-firm-290311/ 2011-03-29T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-invest-16m-in-slough-manufacturing-facility-290311/ 2011-03-29T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ecron-acunova-acquires-majority-stake-in-acronordic-280311/ 2011-03-29T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/lotus-pharma-q4-revenues-up-209-290311/ 2011-03-29T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/curacyte-completes-second-interim-analysis-of-phase-iii-phoenix-trial-290311/ 2011-03-29T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/asterand-5am-solutions-to-jointly-develop-virtual-biobanking-software-300311/ 2011-03-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharma-initiates-ckd-drug-phase-1-clinical-study-300311/ 2011-03-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/protagen-to-apply-uniarray-technology-for-biogen-300311/ 2011-03-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-valeant-pharma-epilepsy-drug-receives-ec-marketing-authorization-300311/ 2011-03-30T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-initiates-antibody-mediated-rejection-drug-trial-300311/ 2011-03-30T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/graffinity-pharma-signs-research-pact-with-shionogi-300311/ 2011-03-30T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/intercept-initiates-nonalcoholic-steatohepatitis-drug-trial-300311/ 2011-03-30T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-minophagen-sign-japan-licensing-pact-for-ctcl-drug-300311/ 2011-03-30T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/oracle-unveils-health-sciences-clinical-development-center-31-300311/ 2011-03-30T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharma-seeks-to-acquire-cephalon-300311/ 2011-03-30T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/microchips-gets-new-us-patent_300311/ 2011-03-30T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-composition-of-matter-patent-for-synavive-zalicus-300311/ 2011-03-30T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-pharma-completes-patient-recruitment-in-two-phase-iii-libigel-trials-300311/ 2011-03-30T09:36:00+00:00 https://www.pharmaceutical-business-review.com/news/israeli-government-approves-cel-sci-to-start-multikine-phase-iii-trial-300311/ 2011-03-30T09:51:00+00:00 https://www.pharmaceutical-business-review.com/news/moffitt-cancer-center-chooses-oracle-health-sciences-solutions-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hamamatsu-photonics-releases-imagem-1k-emccd-camera-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nber-selects-medidata-solutions-to-assess-clinical-trial-costs-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-concludes-first-clinical-trial-in-ox51-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nyu-licenses-microrna-33a-microrna-33b-intellectual-property-to-regulus-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nile-therapeutics-gets-fda-fast-track-status-for-cenderitide-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/icon-chooses-oracle-health-sciences-labpas-solution-for-phase-i-clinical-trials-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tibet-pharma-fy10-revenue-rises-41-310311/ 2011-03-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-to-use-bioclinica-new-enterprise-demand-aggregator-310311/ 2011-03-30T22:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-seeks-re-evaluation-of-chmp-negative-opinion-on-vectibix-310311/ 2011-03-31T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-receives-positive-fda-feedback-for-montelukast-sodium-osf-310311/ 2011-03-31T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/achillion-reports-positive-results-from-hcv-drug-study-310311/ 2011-03-31T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-begin-prostate-cancer-drug-study-310311/ 2011-03-31T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-millennium-takeda-monet1-phase-3-trial-fails-to-meet-primary-objective-310311/ 2011-03-31T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-acquires-gsk-oral-penicillin-facility-in-us-310311/ 2011-03-31T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/newron-in-pact-with-merck-serono-310311/ 2011-03-31T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/spherix-revenues-up-in-fy-10-310311/ 2011-03-31T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmasset-starts-hcv-drug-phase-2b-atomic-trial-310311/ 2011-03-31T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/promius-pharma-valeant-pharma-ink-pact-for-cloderm-cream-010411/ 2011-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-biosciences-to-receive-mexican-patent-for-ed-drug-010411/ 2011-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-scientific-receives-barda-grant-for-laninamivir-development-010411/ 2011-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-closes-deltex-pharma-010411/ 2011-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mitomics-introduces-prostate-core-mitomic-test-010411/ 2011-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-deploy-medidata-designer-010411/ 2011-03-31T21:36:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-pharma-to-launch-anemia-drug-010411/ 2011-04-01T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-knopp-begin-enrollment-in-als-drug-study-010411/ 2011-04-01T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-acl-surgery-drug-fails-in-phase-iii-trials-010411/ 2011-04-01T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-virco-virology-presents-realize-trial-results-010411/ 2011-04-01T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-hcv-drug-meets-primary-end-point-in-phase-ii-study-010411/ 2011-04-01T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/asterand-bioseek-receive-us-patents-for-biomap-systems-technology-010411/ 2011-04-01T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-screens-first-subject-in-alzheimers-dug-trial-010411/ 2011-04-01T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/dutch-government-sanctions-eur12m-to-to-bbb-for-brain-cancer-trial-010411/ 2011-04-01T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-discovers-gbr-401-initiates-ind-studies-010411/ 2011-04-01T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/laboratoires-thea-acquires-novartis-ophthalmic-products-commercialization-rights-010411/ 2011-04-01T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-tightens-rules-for-cough-cold-or-allergy-related-medicines-010411/ 2011-04-01T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-pharma-starts-prt062607-phase-1-trial-010411/ 2011-04-01T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fero-industries-delivers-sucanon-third-shipment-to-merck-010411/ 2011-04-01T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-pharma-presents-livatag-phase-ii-follow-up-results-010411/ 2011-04-01T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-plans-to-intiate-copd-drug-phase-iiiiv-study-010411/ 2011-04-01T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-pharma-concludes-patient-recruitment-in-aln-vsp-phase-i-trial/ 2011-04-01T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/acadia-pharma-extends-research-pact-with-allergan-010411/ 2011-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/percivia-appoints-new-ceo-040411/ 2011-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/regado-reports-positive-results-from-anticoagulation-drug-study-040411/ 2011-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/algeta-inks-research-agreement-with-genzyme-040411/ 2011-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/queens-university-almac-develop-new-cancer-treatment-040411/ 2011-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibn-ibm-research-jointly-develop-biodegradable-polymer-nanoparticles-040411/ 2011-04-03T20:41:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-sets-to-start-phase-3-bi-hcv-drug-trials-040411/ 2011-04-03T21:58:00+00:00 https://www.pharmaceutical-business-review.com/news/autogenomics-pgxl-form-pharmacogenetics-collaboration-040411/ 2011-04-03T21:59:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-introduces-drug-for-low-testosterone-treatment-in-us-040411/ 2011-04-03T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/uluru-q4-revenues-up-040411/ 2011-04-04T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/invida-roche-partner-to-commercialize-market-primary-care-products-in-korea-040411/ 2011-04-04T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/intercell-novartis-to-advance-pseudomonas-vaccine-study-040411/ 2011-04-04T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-in-licensing-rd-pact-with-prism-biolab-040411/ 2011-04-04T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-files-dymista-nda-with-fda-040411/ 2011-04-04T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-releases-absorb-bioresorbable-vascular-scaffold-study-results-040411/ 2011-04-04T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-designates-new-president-ceo-050411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-awards-48m-grant-to-sequella-050411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dabigatran-etexilate-150mg-superior-to-warfarin-in-stroke-prevention-boehringer-ingelheim-050411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ccl-industries-takes-over-sertech-060411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/deutsche-beteiligungs-to-acquire-romaco-group-060411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lanxess-establishes-new-company-in-dubai-060411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/berg-diagnostics-introduces-molecular-diagnostics-services-products-050411/ 2011-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharma-latanoprost-ophthalmic-solution-obtains-fda-approval-050411/ 2011-04-05T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/atlanticare-deploys-medai-risk-navigator-050411/ 2011-04-05T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/stealth-reports-positive-results-from-ischemia-reperfusion-injury-study-050411/ 2011-04-05T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-receives-us-patent-for-methods-of-preparing-pharmaceutical-film-050411/ 2011-04-05T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-suven-life-science-to-manufacture-bulk-drugs-050411/ 2011-04-05T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/kkr-to-acquire-pfizer-capsugel-business-for-2375bn-050411/ 2011-04-05T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-receives-notice-of-allowance-for-schizophrenia-drug-050411/ 2011-04-05T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/selvita-to-offer-computational-chemistry-services-to-ipd-050411/ 2011-04-05T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/aastrom-transfers-cell-cassette-manufacturing-to-atek-medical-050411/ 2011-04-05T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/txcell-gets-french-regulatory-approval-to-initiate-phase-iii-clinical-trial-of-tx-rad-050411/ 2011-04-05T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-names-new-ceo-050411/ 2011-04-05T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-fda-negative-response-for-tafamidis-nda-050411/ 2011-04-05T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-pharma-in-pact-with-oman-pharma-050411/ 2011-04-05T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/prostrakan-introduces-abstral-in-us-050411/ 2011-04-05T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bioniche-pharma-introduces-octreotide-acetate-injection-usp-060411/ 2011-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-take-over-inspire-pharma-for-430m-060311/ 2011-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aragen-gets-niaid-contract-to-develop-monoclonal-antibodies-060411/ 2011-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/geno-obtains-new-patent-for-nitrosyl-nitric-oxide-product-060411/ 2011-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evolva-to-buy-abunda-nutrition-060411/ 2011-04-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharsight-introduces-advanced-phoenix-software-suite-060411/ 2011-04-05T22:01:00+00:00 https://www.pharmaceutical-business-review.com/news/oncothyreon-initiates-enrolment-in-brain-tumour-drug-study-060411/ 2011-04-06T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-begins-diabetes-drug-study-060411/ 2011-04-06T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/gliamed-licenses-rils-to-la-jolla-pharma-060411/ 2011-04-06T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-signs-licensing-pact-with-sunesis-pharma-060411/ 2011-04-06T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/biowa-obt-in-potelligent-technology-license-agreement-060411/ 2011-04-06T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/aptiv-solutions-establishes-adaptive-clinical-trials-innovation-center-060411/ 2011-04-06T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/jjprd-reports-positive-clinical-results-for-rivaroxaban-060411/ 2011-04-06T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funds-phrixus-pharma-to-support-dmt-heart-failure-program-060411/ 2011-04-06T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharma-initiates-phentermine-hcl-375mg-tablets-shipping-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alcana-university-of-british-columbia-alnylam-widen-research-pact-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-pharma-files-soliris-marketing-applications-with-fda-ema-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/supergen-astex-sign-definitive-merger-agreement-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-to-initiate-phase-iii-head-neck-cancer-drug-trial-in-india-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mssny-chooses-e-mds-for-ehr-adoption-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kellbenx-adnagen-ink-licensing-pact-070411/ 2011-04-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-xenoport-win-fda-approval-for-horizant-extended-release-tablets-070411/ 2011-04-07T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-astrazeneca-medullary-thyroid-cancer-drug-070411/ 2011-04-07T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-meda-enter-into-agreement-for-elidel-cream-1-070411/ 2011-04-07T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/alda-pharma-t36-formulation-patent-application-gets-canadian-approval-070411/ 2011-04-07T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/biotie-therapies-initiates-parkinsons-disease-drug-trial-070411/ 2011-04-07T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-to-develop-controlled-release-formulation-070411/ 2011-04-07T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-files-grass-mata-mpl-maa-with-swissmedic-070411/ 2011-04-07T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/avila-therapeutics-releases-btk-inhibitor-positive-clinical-data-070411/ 2011-04-07T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/siro-starts-operations-in-malaysia-070411/ 2011-04-07T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/vbl-therapeutics-presents-vascular-disruptive-agent-preclinical-data-070311/ 2011-04-07T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/marinus-pharma-receives-new-us-patent-for-ganaxolone-070411/ 2011-04-07T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pays-10m-milestone-to-array-biopharma-080411/ 2011-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-establishes-new-subsidiary-in-brazil-080411/ 2011-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-pharma-is-pharma-merge-to-form-pan-european-specialty-pharma-firm-080411/ 2011-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-launches-cuvposa-oral-solution-080411/ 2011-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-banner-pharmacaps-in-softgel-capsule-products-supply-agreement-080411/ 2011-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-in-pact-with-parnell-manufacturing-080411/ 2011-04-08T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/dzs-joins-medidata-technology-partner-program-080411/ 2011-04-08T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-releases-positive-results-from-breast-cancer-drug-trial-080411/ 2011-04-08T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-initiate-dme-drug-phase-3-trial-080411/ 2011-04-08T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-intiates-patient-enrollment-in-pedigree-clinical-trial-080411/ 2011-04-08T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-levofloxacin-oral-solution-wins-fda-tentative-approval-080411/ 2011-04-08T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/heilongjiang-fda-gives-production-license-for-13-products-china-sky-one-medical-080411/ 2011-04-08T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/zacharon-pharma-pfizer-form-rd-collaboration-080411/ 2011-04-08T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/tapimmune-gets-uspto-noa-for-vaccine-composition-with-tap-080411/ 2011-04-08T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-unichem-divalproex-sodium-delayed-release-tablets-anda-080411/ 2011-04-08T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nextpharma-installs-new-encapsulation-machine-at-gottingen-cts-facility-080411/ 2011-04-08T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-inks-loi-to-take-over-indian-dermatology-company-080411/ 2011-04-08T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/teklynx-unveils-electronic-labeling-software-solution-for-life-sciences-firms-110411/ 2011-04-10T19:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-acquires-genzyme-110411/ 2011-04-10T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-acquires-bergamo-in-brazil-110411/ 2011-04-11T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-files-moxifloxacin-anda-with-fda-110411/ 2011-04-11T00:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dainippon-sumitomo-boston-biomedical-in-anti-cancer-drug-collaboration-110411/ 2011-04-11T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/viroxis-gets-fda-approval-for-hpv-drug-initiates-phase-ii-trial-080411/ 2011-04-11T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-antares-pharma-anturol-gel-nda-110411/ 2011-04-11T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-ophthalmic-solution-gets-fda-tentative-approval-110411/ 2011-04-11T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-solubility-enhancing-drug-formulation-technology-gets-us-patent-110411/ 2011-04-11T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-selects-lonza-as-mycotool-mycoplasma-pcr-assays-distributor-110411/ 2011-04-11T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/independent-dmc-suspends-s-aureus-vaccine-phase-iiiii-trial-merck-intercell-110411/ 2011-04-11T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/epo-issues-new-patent-to-kinaxo-biotechnologies-110411/ 2011-04-11T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-support-immatics-cancer-vaccine-clinical-development-program-110411/ 2011-04-11T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-provides-contrafect-with-access-to-antibody-libraries-autocal-110411/ 2011-04-11T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/diamyd-medical-releases-np2-enkephalin-phase-i-trial-results-110411/ 2011-04-11T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/heptares-takeda-pharma-sign-drug-discovery-agreement-110411/ 2011-04-11T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-novartis-in-sativex-licensing-pact-110411/ 2011-04-11T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-initiates-schizophrenia-drug-study-140411/ 2011-04-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-sun-pharma-form-branded-generics-jv-120411/ 2011-04-11T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-selects-dhl-as-new-logistics-provider-120411/ 2011-04-11T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/apeptico-commences-phase-i-pulmonary-oedema-drug-clinical-trial-120411/ 2011-04-11T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-europe-names-new-ceo-120411/ 2011-04-11T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/merz-pharma-introduces-mederma-skin-care-for-scars-gel-stretch-marks-therapy-in-canada-120411/ 2011-04-11T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/adventrx-pharma-takes-over-synthrx-120411/ 2011-04-11T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/jjprd-schizophrenia-drug-obtains-fda-approval-120411/ 2011-04-11T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-biotechnology-receives-japanese-patent-120411/ 2011-04-11T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-grants-funding-to-biocontrol-120411/ 2011-04-12T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-biotech-releases-human-growth-hormone-phase-2-trial-results-120411/ 2011-04-12T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cellmid-reveals-mk-preclinical-trial-results-120411/ 2011-04-12T03:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pharmaceutical-business-review-launches-global-pharmaceutical-industry-survey-120411/ 2011-04-12T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/late-acting-insecticide-delays-insecticide-resistance-in-mosquitoes-university-of-surrey-120411/ 2011-04-12T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-plans-to-buy-biophausia-120411/ 2011-04-12T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/caliper-collaborates-with-denver-based-catholic-health-initiatives-120411/ 2011-04-12T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-pharma-watson-pharma-suspend-uracyst-pact-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/marinus-pharma-receives-grant-to-study-ganaxolone-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmathene-doses-first-patient-in-inhalational-anthrax-drug-phase-i-trial-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharma-in-pact-with-pharma-firm-to-develop-cobacyte-coboral-technologies-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-pharma-receives-two-us-patents-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patents-to-biodesix-blood-based-oncology-tests-130411/ 2011-04-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/szeged-software-selects-magic-software-unipaas-application-130411/ 2011-04-13T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/medline-chooses-gt-nexus-cloud-based-logistics-platform-180411/ 2011-04-13T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-afinitor-tablet-gets-fda-advisory-committee-recommendation-130411/ 2011-04-13T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-concludes-perrigo-allegan-facility-re-inspection-130411/ 2011-04-13T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-signs-research-pact-with-samyang-130411/ 2011-04-13T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-selects-innovatix-as-nyloxin-distributor-in-us-130411/ 2011-04-13T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dimerix-takeda-cambridge-ink-research-agreement-130411/ 2011-04-13T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/alliqua-submits-patent-application-for-transdermal-delivery-technology-130411/ 2011-04-13T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/5n-plus-acquires-mcp-group-130411/ 2011-04-13T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/4sc-treats-first-patient-in-phase-i-topas-study-130411/ 2011-04-13T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/cellmid-signs-agreement-with-antitope-130411/ 2011-04-13T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-reveals-5-year-data-from-neupro-study-140411/ 2011-04-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/proteon-starts-patient-recruitment-in-ckd-drug-phase-2-trial-140411/ 2011-04-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-pharmatech-hemispherx-ink-clinical-development-pact-140411/ 2011-04-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-chooses-upp-technology-irms360-enterprise-solution-suite-140411/ 2011-04-14T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-receives-fda-acceptance-for-bio-t-gel-nda-filing-140411/ 2011-04-14T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/tripos-releases-d360-version-55-140411/ 2011-04-14T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-otc-fexofenadine-hcl-tablets-140411/ 2011-04-14T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/4sc-licenses-resminostat-development-rights-to-yakult-honsha-in-japan-140411/ 2011-04-14T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-aurigene-ink-debio-1142-development-pact-140411/ 2011-04-14T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amunix-signs-research-agreement-with-biogen-idec-140411/ 2011-04-14T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-seeks-fda-orphan-drug-status-for-rayva-140411/ 2011-04-14T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/valirx-partners-with-imperial-college-oxford-university-140411/ 2011-04-14T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharma-acquires-apthera-140411/ 2011-04-14T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/progenitor-cell-therapy-facility-gets-fact-accreditation-180411/ 2011-04-14T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-millennium-to-participate-in-anti-cancer-agent-phase-iii-trial-140411/ 2011-04-14T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-receives-european-patent-for-transvax-140411/ 2011-04-14T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/champions-oncology-licenses-irinophore-c-to-cdrd-bc-cancer-agency-collaboration-140411/ 2011-04-14T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/epo-issues-new-patent-to-oncogenex-140411/ 2011-04-14T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/llnl-awards-second-research-contract-to-trius-150411/ 2011-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-pharma-to-take-over-minority-interest-in-unimark-150411/ 2011-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-ra-drug-meets-primary-endpoint-in-phase-3-study-150411/ 2011-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sbio-starts-dosing-in-phase-2-advanced-lymphoid-malignancies-drug-trial-150411/ 2011-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/qbc-sells-star-hematology-analyzers-to-us-navy-150411/ 2011-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ert-to-offer-epro-solutions-to-pharma-firms-150411/ 2011-04-14T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ortho-mcneil-calls-off-topamax-100mg-tablets-150411/ 2011-04-15T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-to-terminate-ra-drug-phase-ii-trial-150411/ 2011-04-15T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-sativex-oromucosal-spray-receives-czech-republic-approval-150411/ 2011-04-15T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/isofol-medical-recruits-first-patient-in-rectal-cancer-drug-phase-iii-trial-150411/ 2011-04-15T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-introduces-hypertension-drug-edarbi-in-us-150411/ 2011-04-15T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-pharmaceutical-completes-chromatographic-fingerprints-research-150411/ 2011-04-15T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/the-urology-company-vaginal-dryness-treatment-gets-uk-nhs-approval-150411/ 2011-04-15T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-filestyverb-maa-with-ema-150411/ 2011-04-15T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-pharma-ad-drug-clinical-trial-meets-primary-outcome-150411/ 2011-04-15T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-reports-five-year-alemtuzumab-phase-2-data-150411/ 2011-04-15T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/wellmune-wgp-reduces-ragweed-allergy-symptoms-biothera-150411/ 2011-04-15T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-research-links-rls-to-cv-disease-150411/ 2011-04-15T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-amylin-alkermes-bydureon-receive-chmp-positive-opinion-150411/ 2011-04-15T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/eternal-energy-adds-antioxidant-quercetin-to-eternal-energy-shot-190411/ 2011-04-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-pharma-q1-revenues-fall-180411/ 2011-04-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-tobacco-torii-pharma-initiate-zerenex-phase-3-trial-180411/ 2011-04-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-pharma-wins-fda-acceptance-for-vegf-trap-eye-review-180411/ 2011-04-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-stanford-university-bio-x-ink-research-pact-180411/ 2011-04-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-to-eli-lilly-epi-drug-180411/ 2011-04-18T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/active-biotech-ipsen-to-jointly-develop-cancer-drug-180411/ 2011-04-18T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-obtains-fda-final-approval-for-mdd-drug-180411/ 2011-04-18T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/nabriva-reveals-absssi-drug-phase-ii-trial-results-180411/ 2011-04-18T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-commences-nsclc-drug-phase-iii-trial-180411/ 2011-04-18T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-pharma-widens-febuxostat-business-180411/ 2011-04-18T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/dea-approves-pharmatek-to-analyze-controlled-substances-180411/ 2011-04-18T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-receives-fda-approval-for-sjia-drug-180411/ 2011-04-18T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-on-boehringer-ingelheim-dabigatran-etexilate-180411/ 2011-04-18T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-stedim-introduces-clipster-aseptic-disconnector-180411/ 2011-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-files-acnex-maa-in-europe-190411/ 2011-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stirling-products-starts-manufacturing-operations-at-canadian-pharma-plant-190411/ 2011-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-allows-acorda-ampyra-patent-application-190411/ 2011-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-diagnostics-launches-accutype-il28b-test-190411/ 2011-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-avonex-pen-receives-chmp-positive-opinion-190411/ 2011-04-19T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-tau-pharma-gets-fda-approval-to-manufacture-l-asparaginase-190411/ 2011-04-19T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sosei-copd-drug-phase-iii-trial-meets-primary-endpoint-novartis-190411/ 2011-04-19T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-q1-net-sales-up-16-190411/ 2011-04-19T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/laiyang-jiangbo-pharma-to-acquire-xinkangqi-190411/ 2011-04-19T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-seattle-genetics-sign-second-adc-research-pact-190411/ 2011-04-19T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-labs-introduces-contraceptive-pill-seasonique-in-canada-190411/ 2011-04-19T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-taro-pharma-imiquimod-cream-5-anda-190411/ 2011-04-19T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/thorne-research-forms-joint-venture-with-integrative-health-resources-190411/ 2011-04-19T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/avantium-spins-off-pharma-business-to-form-crystallics-190411/ 2011-04-19T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-updates-on-alli-safety-profile-190411/ 2011-04-19T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-pharma-recruits-first-patient-in-circus-study-190411/ 2011-04-19T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-cytokinetics-initiate-heart-failure-drug-phase-iib-trial-200411/ 2011-04-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/calhipso-chooses-athenahealth-ehr-200411/ 2011-04-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/albemarle-q1-net-sales-up-20-210411/ 2011-04-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synapcell-signs-epilepsy-research-agreement-with-medgenesis-200411/ 2011-04-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ambry-genetics-adds-roche-applications-certification-to-portfolio-200411/ 2011-04-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-nutrascience-ache-laboratories-sign-licensing-pact-200411/ 2011-04-20T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-amira-pharma-ipf-drug-200411/ 2011-04-20T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-acquires-azimilide-worldwide-rights-from-blue-ash-therapeutics-200411/ 2011-04-20T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-pharma-sells-jnj-q2-development-rights-to-furiex-200411/ 2011-04-20T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-names-new-ceo-200411/ 2011-04-20T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-nanosystems-alnylam-ink-pact-200411/ 2011-04-20T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-packaging-technology-unveils-new-disposable-filling-system-concept-200411/ 2011-04-20T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-receives-us-patent-for-sativex-as-cancer-pain-treatment-200411/ 2011-04-20T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-closes-fundraising-to-develop-allergy-therapies-200411/ 2011-04-20T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/vicept-therapeutics-reports-v-101-positive-second-phase-ii-results-200411/ 2011-04-20T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-starts-absssi-drug-phase-3-trial-200411/ 2011-04-20T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-pharma-to-manufacture-reazin-for-tg-united-200411/ 2011-04-20T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/hebei-aoxing-api-pharmaceutical-adopts-macfarlan-smith-technology-200411/ 2011-04-20T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bluebird-receives-additional-30m-in-financing-200411/ 2011-04-20T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharma-introduces-famciclovir-tablets-210411/ 2011-04-20T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-microdose-therapeutx-ink-licensing-pact-210411/ 2011-04-20T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-seeks-colesevelam-hci-625mg-tablets-marketing-approval-210411/ 2011-04-20T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mdblackbox-introduces-new-emr-suite-210411/ 2011-04-21T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-revenues-up-in-q1-210411/ 2011-04-21T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pmo-drug-trial-meets-primary-endpoint-amgen-ucb-210411/ 2011-04-21T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-commences-phase-1-trial-in-lupus-program-210411/ 2011-04-21T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-life-sciences-starts-ad-drug-dosing-in-phase-i-clinical-trial-210411/ 2011-04-21T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/neurelis-concludes-patient-dosing-in-intranasal-diazepam-phase-i-trial-210411/ 2011-04-21T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-licenses-argent-gene-expression-regulation-technology-to-regenx-210411/ 2011-04-21T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/wedgewood-pharmacy-to-compound-leukemia-drug-210411/ 2011-04-21T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/altacor-in-licensing-pact-with-ophthalmopharma-for-eyebar-210411/ 2011-04-21T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/hormel-health-labs-rolls-out-healthyshot-with-wellmune-wgp-210411/ 2011-04-21T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/otc-manufactures-recieve-fda-warning-210411/ 2011-04-21T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-q1-net-sales-down-210411/ 2011-04-21T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-aicuris-hcmv-drug-210411/ 2011-04-21T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-signs-shanghai-pharma-to-expand-its-business-in-china-210411/ 2011-04-21T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-net-sales-up-12-210411/ 2011-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-sanofi-start-pediatric-vaccine-phase-iii-trial-220411/ 2011-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gtg-to-co-develop-cancer-product-with-pharma-firm-220411/ 2011-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lipacreon-receives-japanese-approval-abbott-japan-eisai-230411/ 2011-04-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-breast-cancer-drug-obtains-japanese-approval-250411/ 2011-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/study-unveils-mechanism-for-b-cell-differentiation-in-immune-response-rcai-270611/ 2011-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/infogard-certifies-azzly-ehrpmphr-as-complete-ehr-250411/ 2011-04-24T19:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-sanofi-pasteur-menactra-use-250411/ 2011-04-25T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-pharma-delays-imo-2125-phase-2-trial-initiation-250411/ 2011-04-25T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/stg-acquires-impactrx-250411/ 2011-04-25T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-approval-to-daiichi-sankyo-lixiana-250411/ 2011-04-25T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharma-fusilev-rtu-formulation-receives-fda-approval-250411/ 2011-04-25T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/nm-hitrec-selects-sage-healthcare-division-as-ehr-provider-250411/ 2011-04-25T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/nano-terra-licenses-pharmacomer-technology-to-kadmon-pharma-250411/ 2011-04-25T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-to-teikoku-pharma-for-aricept-patch-250411/ 2011-04-25T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-pharma-expands-collaboration-with-bayer-healthcare-250411/ 2011-04-25T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-revenues-up-in-q1-250411/ 2011-04-25T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/chugai-pharma-renal-anemia-drug-recieves-japanese-approval-250411/ 2011-04-25T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-cns-drug-receives-fda-nod-250411/ 2011-04-25T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/msd-in-india-selects-sun-pharma-to-market-diabetes-drugs-250411/ 2011-04-25T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sequella-maxwell-sign-pact-to-develop-commercialize-tb-drug-250411/ 2011-04-25T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/convergence-pharma-commences-pain-drug-phase-i-trial-250411/ 2011-04-25T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/luitpold-pharma-temporarily-stops-drug-manufacturing-at-shirley-plant-250411/ 2011-04-25T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmatek-adds-spray-drying-to-drug-manufacturing-capabilities-260411/ 2011-04-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/applied-visual-sciences-launches-tb-diagnostic-test-in-india-260411/ 2011-04-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharma-introduces-letrozole-tablets-usp-25mg-260411/ 2011-04-25T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-taro-pharma-brampton-manufacturing-facility-260411/ 2011-04-25T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-kempharm-to-jointly-develop-adhd-drug-260411/ 2011-04-26T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/urac-grants-full-pbm-accreditation-for-aetna-260411/ 2011-04-26T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-alkem-sign-dyslipidemia-drug-licensing-deal-260411/ 2011-04-26T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cira-dainippon-sumitomo-pharma-ink-research-partnership-260411/ 2011-04-26T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/harlan-laboratories-names-new-president-of-contract-research-services-260411/ 2011-04-26T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-bio-licenses-clinical-biomarker-database-to-biomarker-qualification-group-260411/ 2011-04-26T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-nanopore-obtains-25m-funds-from-investors-260411/ 2011-04-26T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/oragenics-oral-care-ingredient-receives-us-patent-260411/ 2011-04-26T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tec-labs-to-address-issues-regarding-staphaseptic-mrsa-prevention-claims-260411/ 2011-04-26T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/aafi-selects-dksh-to-distribute-pharma-personal-care-products-in-vietnam-260411/ 2011-04-26T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-lift-allergy-therapeutics-inds-clinical-hold-260411/ 2011-04-26T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-launches-thyroid-cancer-drug-in-us-260411/ 2011-04-26T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/gumlink-takes-over-50-stake-in-tab-labs-020511/ 2011-04-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-awards-gmp-certfication-to-aoxing-pharma-270411/ 2011-04-26T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-starts-patient-recruitment-in-hcv-drug-trial-270411/ 2011-04-26T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-gets-dalbavancin-worldwide-development-commercialization-rights-270411/ 2011-04-27T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-bioinvent-dose-first-patient-in-tb-402-phase-iib-trial-270411/ 2011-04-27T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmstar-pharma-to-acquire-24000sqft-manufacturing-facility-270411/ 2011-04-27T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/wolters-kluwer-health-to-take-over-lexi-comp-270411/ 2011-04-27T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-takeda-pharma-file-two-sndas-for-velcade-270411/ 2011-04-27T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/tarix-pharma-recruits-first-patient-in-txa127-phase-1-trial-270411/ 2011-04-27T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/columbia-laboratories-files-prochieve-nda-with-fda-270411/ 2011-04-27T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-medtronic-in-parkinsons-disease-collaboration-270411/ 2011-04-27T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-provectus-pharma-liver-cancer-drug-270411/ 2011-04-27T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/p2d-bioscience-lead-compounds-receive-us-canadian-patent-protection-270411/ 2011-04-27T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/iq-therapeutics-concludes-dosing-in-anthrax-drug-phase-i-trial-270411/ 2011-04-27T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-q1-net-revenue-surges-270411/ 2011-04-27T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-pharma-lomitapide-receives-us-patent-270411/ 2011-04-27T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-reports-cimzia-positive-results-in-ra-patients-270411/ 2011-04-27T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/arbour-group-to-offer-regulatory-compliance-software-services-to-impax-labs-280411/ 2011-04-27T18:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-to-acquire-oystar-subsidiaries-290411/ 2011-04-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/affitech-crt-in-cancer-antibody-development-agreement-280411/ 2011-04-27T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-extends-clonidine-lauriad-european-clinical-trial-280411/ 2011-04-27T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/beactica-janssen-sign-fragment-based-drug-discovery-deal-280411/ 2011-04-27T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/hbi-sells-otc-firm-antula-to-meda-280411/ 2011-04-28T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/acelot-launches-chemical-search-analysis-tools-280411/ 2011-04-28T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-operating-profit-increases-in-q1-2011-280411/ 2011-04-28T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/biovista-enters-into-agreement-with-novartis-280411/ 2011-04-28T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/dyadic-receives-us-patent-280411/ 2011-04-28T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-report-vegf-trap-eye-phase-3-study-positive-results-280411/ 2011-04-28T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-reports-adhd-drug-study-positive-results-280411/ 2011-04-28T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/adherex-enrolls-first-patient-in-eniluracil-phase-2-trial-280411/ 2011-04-28T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-pharma-q1-net-loss-widens-290411/ 2011-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-q3-revenue-up-290411/ 2011-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sct-recruits-first-patient-in-tbi-drug-trial-290411/ 2011-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicare-net-sales-up-in-q1-290411/ 2011-04-28T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-cancer-drug-receives-orphan-drug-status-290411/ 2011-04-28T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-q1-net-sales-fall-290411/ 2011-04-28T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/healthlink-dimensions-partners-with-mmis-290411/ 2011-04-28T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-net-sales-up-in-q1-290411/ 2011-04-29T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-novartis-high-blood-pressure-drug-290411/ 2011-04-29T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-q1-net-revenue-climbs-290411/ 2011-04-29T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-celanese-eva-collaborate-for-drug-eluting-device-combinations-290411/ 2011-04-29T03:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cel-sci-starts-head-neck-cancer-drug-phase-iii-trial-290411/ 2011-04-29T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-receives-milestone-payment-from-oncomed-290411/ 2011-04-29T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/phenomenex-inaugurates-new-head-office-in-india-290411/ 2011-04-29T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-ra-drug-phase-3-studies-results-290411/ 2011-04-29T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/mlsc-funds-umms-rxi-pharma-to-develop-new-als-treatment-290411/ 2011-04-29T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/china-pharma-net-sales-up-in-fy-10-290411/ 2011-04-29T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-centocor-ortho-biotech-prostate-cancer-drug-290411/ 2011-04-29T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/oetc-vaccinates-last-infant-in-tb-efficacy-trial-290411/ 2011-04-29T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/idt-offers-double-quenched-probes-290411/ 2011-04-29T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-revenue-surges-in-q1-290411/ 2011-04-29T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-allows-cel-sci-to-commence-multikine-trial-020511/ 2011-05-01T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-androgel-162-gets-fda-approval-020511/ 2011-05-01T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-q1-sales-up-020511/ 2011-05-01T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/callidus-software-introduces-new-mobile-sales-coaching-solution-020511/ 2011-05-01T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-spectrum-pharma-fusilev-for-metastatic-colorectal-cancer-patients-020511/ 2011-05-02T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/onco-therapies-oncology-facility-in-bengaluru-india-wins-fda-approval-020511/ 2011-05-02T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/centocor-ortho-cancels-trabectedin-nda-020511/ 2011-05-02T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-group-revenues-up-in-q1-020511/ 2011-05-02T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/wilex-licenses-rencarex-us-commercialization-rights-to-prometheus-020511/ 2011-05-02T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/keryx-q1-net-loss-widens-020511/ 2011-05-02T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-pharma-names-interim-ceo-020511/ 2011-05-02T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/tumours-recruit-white-blood-cells-to-reduce-drug-effect-cancer-research-uk-study-020511/ 2011-05-02T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/nupathe-receives-noa-for-zelrix-from-uspto-020511/ 2011-05-02T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/idaho-technology-filmarray-earns-fda-approval-030511/ 2011-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-adhd-drug-030511/ 2011-05-02T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gerd-drug-receives-fda-approval-030511/ 2011-05-02T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicell-q1-revenue-climbs-030511/ 2011-05-02T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/dyadic-nederland-sanofi-pasteur-engen-bio-sign-research-pact-030511/ 2011-05-03T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-otc-minoxidil-foam-030511/ 2011-05-03T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cypress-pharma-rolls-out-generic-elestat-030511/ 2011-05-03T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/oragenics-to-introduce-oral-probiotics-in-australia-new-zealand-030511/ 2011-05-03T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-names-new-ceo-030511/ 2011-05-03T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/althea-signs-supply-pact-with-biotest-030511/ 2011-05-03T03:30:00+00:00